Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospital, Lille
With
ApoPharma
At the end of the study, it will propose to continue the usual quarterly patient follow up, as recommended by the French ALS centers.
Deferiprone can be administered as part of a compassionate use, for patients who want it and who do not have hypoxemia.
We therefore plan a treatment period compassionate relatively short and less than 3 years.
Age
18–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Amyotrophic lateral sclerosis defined in accordance to the El Escorial criteria (possible, probable or defined)
18 to 85 years old patient, male or female
Patient with social security cover
You may not be if
Achieved respiratory defined by a FVC \<70%
Evolution of more than 24 months
Demented subject
Severe malnutrition
Patients with treatment potentially at risk of agranulocytosis and neutropenia
Patients with a history of agranulocytosis or iatrogenic under haematological disease
Incapable of giving consent
Indication against MRI
Indication against lumbar puncture
Patient refused lumbar puncture
Hypersensitivity to iron chelators
Concomitant treatment with antacids containing aluminum
Presence of another serious illness to life-threatening or disabling cons to the use of the treatment mixture of oxygen and nitrous oxide equally